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Expression of lactoferrin in the kidney: Implications for innate cells in these organs seem to be responsible for the pro-
immunity and iron metabolism. duction of LF, and several cell lines originating from
Background. Sequestering of free iron by lactoferrin (LF) these organs have been shown to synthesize LF [7]. Inis important in the defense against bacteria. In a screening for
addition, LF is particularly abundant in secretions, suchLF expression in various organs, high levels of LF mRNA were
as tears, saliva, seminal plasma, and vaginal mucusdetected in human kidney. This indicated that LF is produced
by the kidney and that it may participate in innate immunity [8–11]. LF is also one of the main immune proteins of
of this organ. the neutrophil granulocytes. In bone marrow, the level
Methods and Results. Antibody staining and in situ hybridiza- of LF mRNA is high but ceases after lineage commit-tion of paraffin-embedded kidney sections showed that LF is
ment, and no LF mRNA is found in monocytes andexpressed in cells lining the distal collecting ducts of the me-
dulla. High levels of both protein and mRNA were detected mature neutrophils [polymorphonuclear cells (PMNs)]
in these cells. However, a clear difference in the distribution [12, 13]. Most cell lines derived from hematopoietic cells
of mRNA and protein within the tissue was observed. LF also seem to have lost the capability of synthesizing LF
mRNA was detected along a relatively large portion of the
[7]. In PMNs, the protein is stored in special (secondary)tubuli, whereas LF antigen was found mainly in the very distal
granules where it resides until cellular activation [14].regions of the same tubuli. This indicates that LF is released
by large regions of the tubuli and possibly reabsorbed in the These cells degranulate upon contact with a foreign anti-
most distal parts. Using enzyme-linked immunosorbent assay, gen, via a receptor-mediated mechanism, and release a
only very low LF levels were detected in urine. number of antibacterial and antiviral peptides, includingConclusion. The present study shows that LF is produced
LF [reviewed in 15]. This process is the major source ofby the kidney and that both LF mRNA and protein are distrib-
LF in plasma. After degranulation, LF is cleared fromuted in a highly ordered fashion. This latter finding, together
with the very low levels of LF detected in urine, indicates that the circulation by several separate mechanisms mainly
LF may contribute to the immune defense in the kidney by involving cells of the macrophage/monocyte cell lineage
reduction of available free iron in the urine. Other possibilities [16, 17]. These cells have specific high-affinity receptorsare that LF may play a role in the iron metabolism by recov-
that internalize LF and transfer the bound iron to ferritin,ering free iron from urine and making it available for metabolic
accompanied by the destruction of LF [18].use, and that LF may participate in the antioxidant defense
systems protecting the kidney against nonmicrobial oxidative The major function of LF probably resides in its bacte-
injury, that is, ischemia, reperfusion and inflammation. ricidal effects, either by sequestering free iron [reviewed
in 19] or by the effects of lactoferricin, an antibacterial
peptide generated by proteolytic cleavage of LF [20]. In
Lactoferrin (LF) is an iron-binding protein that is re- addition, LF has been shown to function as a transcrip-
lated in structure to transferrin. LF was first isolated tion factor [21].
from human breast milk [1] and was found later in several Lactoferrin has previously been shown to be present
other organs, such as kidney, gallbladder, lung, pancreas, in urine and fecal samples. However, the levels in these
prostate, seminal vesicle, gut, and liver [2–7]. Specialized samples are relatively low. In infant urine, the maternal
milk has been implicated as the source of LF [22],
whereas the levels in fecal samples of adults probablyKey words: urine, lactoferricin, antibacterial, immune defense, free
iron. reflect secretion from the gallbladder and pancreas [23].
Cells in the rectal mucosa have also been shown to pro-Received for publication March 16, 1999
duce LF [23, 24]. The production of LF by pancreas andand in revised form November 10, 1999
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Several reports have previously indicated the presence CCRGGTCCCTTCTCATRC-39, and 39 primer, 59-TGG
CAGGACTTCTTGCCTTTCA-39.of LF in kidney [2, 25]. However, previously it has not
been known whether LF actually is expressed by resident The primers were used in several amplification reac-
tions, and the nucleotide sequence of the PCR productskidney cells or whether the protein originates from infil-
trating neutrophils. In an earlier report, to our surprise was determined. The sequence was shown to be identical
to the LF sequence (data not shown). However, minorwe detected mRNA for LF in kidney [26]. In the present
study, we investigated the source and the distribution of background bands were detected, which may indicate
low levels of transferrin mRNA in the kidney. However,kidney LF, both at the mRNA and protein levels. We
show that LF is expressed by cells lining the distal tubules the levels were below 10% of the LF signal.
of the medulla. Furthermore, our results indicate that
ImmunohistochemistryLF is produced and released in the upper region of the
tubuli and reabsorbed further downstream along the tu- A standard protocol for immunostaining using the per-
buli, most likely after binding free iron. oxidase antiperoxidase (PAP) amplification system was
used. Briefly, 4 mm sections were cut from paraffin-
embedded, formalin-fixed kidney tissues. The sections
METHODS were deparaffinized and rehydrated. A rabbit polyclonal
RNA preparations anti-LF antibody (a kind gift from Professor Inge Olsson,
Lund, Sweden) was used at a dilution of 1:200 as primaryTotal RNA was prepared from tissue samples from
antibody, followed by application of a sheep antirabbitseven different human kidneys. Four of these kidneys
antibody diluted 1:30 and finally a PAP-complex (Dako,(samples 4 through 7) were transplanted and removed
Carpinteria, CA, USA) diluted 1:80. 3-Amino-9-ethylbecause of rejection [one acute vascular and three kid-
carbazole was used to visualize the PAP complex. En-neys with chronic vascular rejection (CVR)]. The three
dogenous peroxidase was blocked by H2O2 before appli-remaining kidneys (samples 1 through 3) were removed
cation of the first layer. The rabbit polyclonal anti-LFbecause of the presence of small tumors (hypernephro-
antibody was tested for reactivity against purified trans-mas). Normal liver tissue was obtained from areas pres-
ferrin and LF in an Ouchterlony assay. The antiseraent around the tissues obtained by resection of a benign
showed precipitin lines only against purified LF (datatumor. Approximately 25 mg of total RNA from each
not shown). No cross-reactivity was detected againsttissue sample were separated by electrophoresis on dena-
transferrin (data not shown).turing agarose gels containing formaldehyde, followed by
transfer to Hybond N1 nylon membranes (Amersham,
Enzyme-linked immunosorbent assayBuckinghamshire, UK). The Northern blots were hy-
bridized with a 32P-labeled LF cDNA fragment in a solu- A LF-ƒ-EIA kit (BIOXYTECH.S.A.) was purchased
tion containing 7% sodium dodecyl sulfate (SDS) 1 0.25 from R&D Systems (Minneapolis, MN, USA) and was
mol/L Na2HPO4. The hybridization was carried out at used according to the manufacturer’s protocol. Samples
658C overnight and washed under high-stringency condi- were collected, prepared, and stored until being assayed.
tions (1% SDS 1 0.02 mol/L Na2HPO4). The filter was Briefly, the urine samples were centrifuged for five min-
stripped and used for rehybridization with the b-actin utes, and 1.5 mL of the supernatants were stored at
cDNA as probe. 2208C. Tear samples were collected and kept in 2208C.
Samples of saliva were first sonicated and then kept at 48C.
Polymerase chain reaction amplification and Blood samples (10 mL) were withdrawn and transferred
nucleotide sequence analysis either to nonclotting glass tubes [containing ethylene-
diaminetetraacetic acid (EDTA)] or to Vacutainer tubesLactoferrin is homologous to other transferrin-like
for rapid coagulation. The samples of EDTA-treatedgene family members. To study the origin of the hybrid-
blood were diluted 1:1 with EDTA-phosphate-bufferedization signals observed during Northern blot analysis and
saline (PBS) and further fractionated into plasma, pe-in situ hybridizations, polymerase chain reaction (PCR)
ripheral blood leukocytes (PBLs), and PMNs by densityprimers were designed to amplify both transferrin and
LF mRNA. The primers were directed against regions gradient centrifugation using Polymorphprep, Nycomed
AS. Purified cells were washed three times in PBS, resus-that showed full or almost full sequence identity between
LF and transferrin. In the region covered by one of the pended in 1 mL, and counted. From PBLs and PMNs,
triplicates of 50,000 cells were prepared on cytospin glassprimers, LF and transferrin differed in sequence in two
positions. In these positions, both nucleotides were added slides, followed by Giemsa staining to determine the
purity of the cell populations. NP-40 was used to lyzeduring synthesis to give a mixture of two sequence specific
primers in equal amounts (mixed synthesis). The se- PBL and PMN before the enzyme-linked immunosor-
bent assay (ELISA) test.quence of the primers is as follows: 59 primer, 59-TGGC
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In situ hybridization
Four micrometer sections from paraffin-embedded
kidney samples were used in in situ hybridization studies
to localize LF-mRNA. A DNA fragment spanning the
39-prime end of the LF cDNA was used for the 35S radio
labeling of the antisense (by using the T7 polymerase)
and the sense probes (by using the Sp6 polymerase). In
situ hybridization was performed as previously described
[27]. Briefly, the sections were dewaxed in Xylen two Fig. 1. Northern blot analysis of eight different human tissue samples:
three normal (lane 1 through 3), one acute vascular rejected (lane 4),times for five minutes each followed by washing in etha-
three chronic vascular rejected kidneys (lane 5 through 7), and onenol. Next, the sections were rinsed briefly in water fol-
normal liver (lane 8). A large variation in expression levels is observed
lowed by PBS. Protease treatment was performed in a between different patients. However, a good correlation was observed
between the amount of cortex or medulla and the expression levels inhumidified chamber using proteinase K at a concentra-
each sample. Lanes 1, 2, 4, 5, and 6 contain tissue from both medullation of 100 mg/mL in a solution of 0.1 mol/L Tris-HCl and cortex. In contrast, lanes 3 and 7 contain almost only cortical tissue.
and 5 mmol/L EDTA for 15 minutes at 378C. Sections A low level of lactoferrin (LF) mRNA was also detected in the liver
sample. b-actin was used as a control to normalize the loading of RNAwere then washed in PBS and acetylated by incubation
in each sample.
in 0.1 mmol/L triethanolamine, pH 8.0, and 0.25% (vol/
vol) acetic anhydride for 10 minutes at room tempera-
ture. Approximately 5 3 107 cpm/mL of 35S-labeled RNA
probe were applied onto the sections in a solution con- samples were found to contain LF mRNA (Fig. 1). The
taining 2 3 standard saline citrate (SSC), 50% form- size of the LF mRNA was approximately 2.5 kb, which
amide, 10% (wt/vol) dextran, 1 mg/mL of tRNA, 1 mg/mL is in agreement with the size reported for LF mRNA
from other organs [7]. Large variations in expressionof salmon sperm DNA, 2 mg/mL of bovine serum albu-
levels were observed for different regions within themin, and 100 mmol/L dithiothreitol (DTT) and were
kidney. High levels were observed in samples originatinghybridized in a humidified chamber for three to four
from the medulla, whereas low levels were found inhours at 508C. After hybridization, the sections were
samples from the cortex. There were no obvious differ-washed and treated with RNase A and T1. After several
ences between samples originating from normal kidneys,washings, the sections were dehydrated and subjected
rejected kidneys, or kidneys with small tumors (Fig. 1).to autoradiography with photographic emulsion NTB2
Lactoferrin is homologous to other transferrin-like(Eastman Kodak, Rochester, NY, USA). The sections
gene family members. A slight possibility thereby existswere then exposed for two weeks at 48C. Slides were
that the hybridization signals observed in the kidneydeveloped and counterstained with hematoxylin and ex-
samples do not originate from LF but instead are fromamined for LF staining and photographed using a Canon
cross-hybridization to transferrin mRNA. The probeor Leitz light microscope.
used during the Northern blot analysis and the in situ
hybridization originate from the 39 noncoding region of
the LF mRNA, a region that shows a low degree ofRESULTS
sequence identity between LF and transferrin mRNA.Northern blot analyses
The risk of cross-hybridization is thus very low. How-
To determine whether the levels of LF mRNA differ ever, we still wanted to confirm the identity of the hybrid-
between different regions of the kidney and whether the ization signals. A PCR-based analysis of the mRNA was
condition, that is, the presence of tumors, transplantation therefore performed. PCR primers, which amplify both
rejection, or infection, of the kidney influences the LF transferrin and LF mRNA with equal efficiency, were
mRNA levels, samples from seven different kidneys used during the amplification reaction, and the nucleo-
were studied by Northern blot analysis. Four of these tide sequence of the PCR products was determined. The
kidneys (samples 4 through 7) were transplanted and nucleotide sequences were found to be identical to the
removed because of rejection (one acute vascular and LF sequence, and only minor background bands were
three kidneys with CVR). The three remaining kidneys detected (data not shown). In the kidney, LF is the pre-
(samples 1 through 3) were removed because of the dominately expressed member of the transferrin-like
presence of small tumors (hypernephromas). The tissues gene family.
saved as normal were macroscopically and microscopi-
Immunohistochemistrycally normal tissue from samples, which were removed
because of the presence of small tumors. Although a To study the presence of LF antigen in different re-
gions of the kidney, sections from different parts of thelarge variation in expression levels was observed, all
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Fig. 2. Immunohistochemical localization of lactoferrin (LF) in sections of a normal human kidney. Sections of the kidney were incubated with
a polyclonal rabbit anti-LF antibody (B, D, and F ) or with a normal rabbit serum as control (A, C, and E ). (B and D) These show regions from
the medulla where strong staining of distal collecting tubules is observed. In contrast, no staining was detected in tissue sections originating from
the cortical region of the kidney (data not shown). All blood vessels were negative (F).
kidneys were stained with an antibody against LF. Stain- present in two of the otherwise normal kidneys, indicat-
ing that there is no correlation between LF expressioning for LF was found in tubular structures of the medulla
(Fig. 2 B, D), but no signal was detected in the cortical and the state of transformation (data not shown).
region (data not shown). Based on morphological exami-
Enzyme-linked immunosorbent assaynations, the structures that showed positive staining were
identified as the distal collecting tubules (Fig. 2 B, D). How much of the LF produced in the kidney appears
in the urine, and what is the role of LF in the kidney?All samples examined, 1 through 3 and 5 through 7,
were positive for LF (data not shown). However, not all To address these questions, we decided to determine the
LF levels in urine and to relate these values to LF levelstubules stained positively, indicating that LF expression
is restricted to certain tubuli or to certain regions of in other human organs and secretions. Urine, tears, sa-
liva, and blood were collected from six individuals andthe tubuli. No staining was detected in or around blood
vessels (Fig. 2F), and no difference between normal and were prepared as described in the Methods section. The
LF levels in these samples were determined by a sand-rejected kidneys was observed (data not shown). Fur-
thermore, we could not see any staining of tumor tissues wich ELISA (Table 1). Low levels of LF were detected
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Table 1. Lactoferrin levels in urine, saliva, tears, plasma, serum, bacterias by, for example, depleting essential cofactors
PBL, PMN. The levels were determined with a commercial ELISA
like free iron, degrading the bacterial cell wall compo-kit (lactoferrin-ƒ-EIA kit (BIOXYTECH.S.A.).
nents, or using other not yet fully elucidated mechanisms.
Samples N* Lactoferrin levels Range In the kidney, various antibacterial substances have been
Urine 6 75 ng/mL 14–145 identified in response to infections. However, it is not
Saliva 6 51 mg/mL 22–72
clear whether these proteins are present as a result ofTears 5 2.2 mg/mL 1.5–3.3
Plasma 4 1.0 mg/mL 0.8–1.3 neutrophil infiltration or are actually synthesized by the
Serum 4 2.8 mg/mL 1.5–4.3 resident kidney cells. The present findings, with the de-PBL 4 0.4 mg/10 3 7 cells
tection of LF protein and mRNA in the collecting tubulesPMN 4 3.0 mg/10 3 7 cells
of the kidney, show that at least one of these antibacterialAbbreviations are: PBL, peripheral blood leukocyte; PMN, polymorphonu-
clear neutrophil. proteins can be produced by the kidney, which implies
* N indicates the number of tested individuals.
a role of the kidney in its own immune defense.
When comparing the immunohistochemical informa-
tion with the pattern of mRNA expression, a clear differ-
in urine (average concentration 75 ng/mL). Intermediate ence was found. Only a few of the collecting tubules show
levels were found in serum and plasma. High levels were apparent protein staining (Fig. 2 B, D), whereas the in
found in saliva and tears. The concentration within indi- situ hybridizations show massive expression in almost all
vidual blood cell populations was also determined. Blood of the tubules (Fig. 3 B, D, and F). These results suggest
cells was subdivided into PMN, PBL, plasma, and serum. that LF is expressed and secreted throughout the collect-
To determine the purity of the cells in these samples, ing tubules and that LF receptors may be present only
the PMN and PBL cells were fixated on cytospin glass in the distal part of the tubules. In these latter regions,
slides following counterstaining with hematoxylin. Ap- where LF may be reabsorbed, a massive accumulation
proximately 40 fg/cell was detected for total PBL and 0.3 of the protein is seen. A question arises about which
pg/cell for purified PMNs (neutrophils). Approximately receptor is responsible for such reabsorbtion. Studies in
10% neutrophils were detected on the slides with total rats have previously shown that the excretion of iron is
PBL (data not shown). This observation may explain higher in fecal than in urine samples, further indicating
why the PBL samples also were positive in the ELISA. the presence of a receptor-Fe-LF system for iron reab-
sorption in the kidney [28]. LF has previously been shown
In situ hybridization
to bind to a number of cell surface proteins that were
To further study the synthesis of LF in the kidney, originally identified as receptors for other proteins. Two
we analyzed kidney samples by in situ hybridization. A such receptors, LRP and gp330 (megalin), are expressed
cDNA fragment spanning the 39 end of LF mRNA was in rat kidney and have both been shown to bind LF in
used as the probe. Both sense and antisense probes were vitro [29]. These receptors may thus represent potential
employed to study the same kidney samples as those LF receptor candidates mediating endocytosis of iron
used for the immunohistochemical analysis. Using the bound to LF. However, gp330 is only present in proximal
antisense probe, strong staining was seen in the collecting tubuli, arguing against a role in receptor-mediated endo-
tubules of the medulla (Fig. 3 B, D, and F). In contrast, cytosis of LF produced by the kidney [30]. Furthermore,
no expression was observed in the cortical region, in LRP is only expressed by dendritic interstitial cells and
blood vessels, or in other regions that may contain infil-
not by cells lining the distal tubules [31], indicating that
trating neutrophils (data not shown). In addition, no
it is not involved in LF reabsorption. Another not yethybridization was detected in glomeruli (data not shown).
identified receptor(s) is therefore probably involved inUsing the sense probe, no staining was detected in any
this process. The presence of large amounts of LF proteinregion of the kidney (Fig. 3 A, C, and E).
in the tubuli but very low levels in urine also indicates
additional functions of kidney LF. An interesting possi-
DISCUSSION bility is that LF participates in the iron metabolism by
absorbing free iron from the urine, thereby making itLactoferrin, lysozyme, defensins, azurozidin, and dif-
available for metabolic use. It is also possible that as anferent serine proteases, that is, N-elastase, cathepsin G,
iron chelator and antioxidant, renal tubular LF partici-and proteinase 3, all contribute to the first line of defense
against bacterial infections. Together they kill invading pates in antioxidant defense systems that protect the
c
Fig. 3. In situ hybridization of a human kidney sample (sample 6). (A, C, and E, negative control) Hybridization of a section from the medulla
of a kidney with a LF sense probe (34, 310, and 340). (B, D and F ) Sections of human kidney incubated with a LF antisense probe.
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